Frontlight ResearchEarly access
Acute myeloid leukaemia trials in United States
334 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleRevumenib in Combination With 7+3 + Midostaurin in AML
- Where
- Boston, New Haven
- Age
- 18 years to 75 years
- People
- 22
- Run by
- Richard Stone, MD
See details and how to joinNCT06313437 - Phase 1Taking peopleSafety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
- Where
- Houston, New York
- Age
- 18 years and over
- People
- 24
- Run by
- Remedy Plan, Inc.
See details and how to joinNCT07107126 - Phase 1/2Taking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Baltimore, Boston, Buffalo, Chapel Hill, Charleston, Charlottesville, Chicago, Columbus, Denver, Durham, Eugene, Fairfax, Houston, Miami, Morristown, Nashville, New Brunswick, Newport Beach, New York, Norfolk, Palo Alto, Philadelphia, Pittsburgh, Salt Lake City, Tampa, Washington D.C., Winston-Salem
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - Phase 1/2Taking peoplePhase IB/II of CPX-351 for Relapse Prevention in AML
- Where
- Hackensack, Philadelphia, Washington D.C.
- Age
- 18 years and over
- People
- 24
- Run by
- Georgetown University
See details and how to joinNCT04990102 - Phase 2Taking peopleA Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Where
- Birmingham, Boston, Chapel Hill, Charlottesville, Detroit, Duarte, Houston, Miami, New York, Palo Alto, Portland, Seattle, Westwood
- Age
- 18 years to 66 years
- People
- 358
- Run by
- Center for International Blood and Marrow Transplant Research
See details and how to joinNCT06859424 - Phase 1Taking peopleA Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- Where
- Boston, Chicago, Duarte, Houston, Nashville, New York, Palo Alto, Philadelphia, St Louis, Tampa
- Age
- 12 years and over
- People
- 72
- Run by
- Crossbow Therapeutics, Inc.
See details and how to joinNCT06994676 - Phase 2Taking peopleCord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
- Where
- New York
- Age
- Up to 21 years
- People
- 31
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04644016 - Phase 1Taking peopleA Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Where
- Ann Arbor, Atlanta, Augusta, Aurora, Austin, Baltimore, Boston, Buffalo, Chicago, Cleveland, Columbus, Dallas, Denver, Detroit, Durham, Fairway, Hackensack, Houston, Iowa City, Jacksonville, Jefferson, La Jolla, Los Angeles, Louisville, Madison, Maywood, Milwaukee, Minneapolis, Nashville, New Brunswick, New Haven, New York, Oklahoma City, Orange, Philadelphia, Phoenix, Rochester, Stony Brook, Worcester
- Age
- 18 years and over
- People
- 420
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT05735184 - Phase 1Taking peopleVenetoclax Basket Trial for High Risk Hematologic Malignancies
- Where
- Atlanta, Aurora, Boston, Chicago, San Francisco
- Age
- 1 year to 40 years
- People
- 30
- Run by
- Andrew E. Place, MD
See details and how to joinNCT05292664 - No phaseEnrolling by invitationLong-Term Follow-up Study
- Where
- Atlanta, Augusta, Birmingham, Charlotte, Cincinnati, Cleveland, Dallas, Denver, Gilbert, Hackensack, Houston, Iowa City, Irvine, La Jolla, Lexington, Louisville, Miami, Milwaukee, Morristown, Nashville, New York, Orlando, Philadelphia, Richmond, Salt Lake City, Scottsdale, Seattle, The Bronx
- Age
- 18 years and over
- People
- 150
- Run by
- Caribou Biosciences, Inc.
See details and how to joinNCT05332054 - Phase 1Taking peopleTazemetostat and Palbociclib With CPX-351for R/R AML
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 24
- Run by
- Thomas Jefferson University
See details and how to joinNCT05627232 - Phase 1Taking peopleA Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 40
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05748197 - Phase 1Taking peopleTrial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
- Where
- Birmingham
- Age
- 18 years to 75 years
- People
- 20
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07044544 - Phase 1Taking peopleFHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
- Where
- The Bronx
- Age
- 18 years and over
- People
- 33
- Run by
- Montefiore Medical Center
See details and how to joinNCT07283094 - Phase 1Taking peopleCPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
- Where
- Tampa
- Age
- 18 years to 70 years
- People
- 18
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT05558124 - Phase 2Taking peopleDiscontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
- Where
- Tampa
- Age
- 18 years and over
- People
- 37
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06511882 - Phase 1/2Taking peopleCytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
- Where
- Cincinnati
- Age
- 2 years and over
- People
- 20
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT05580601 - Phase 2Taking peopleA Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 30
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06773208 - Phase 1Taking peopleVenetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- Where
- Cincinnati
- Age
- 1 year to 39 years
- People
- 21
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT03826992 - Phase 1Taking peopleA Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
- Where
- Boston, Houston, Nashville, Portland, Rochester, Stanford, Tampa
- Age
- 18 years and over
- People
- 105
- Run by
- Solu Therapeutics, Inc
See details and how to joinNCT06950034 - Phase 1/2Taking peopleA Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
- Where
- Boston
- Age
- 18 years and over
- People
- 31
- Run by
- Jacqueline Garcia, MD
See details and how to joinNCT07148180 - Phase 1Taking peopleCAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- Where
- Memphis
- Age
- Up to 21 years
- People
- 18
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06326463 - Phase 1Taking peopleCC-486 and Venetoclax for Acute Myeloid Leukemia
- Where
- Aurora
- Age
- 18 years to 100 years
- People
- 35
- Run by
- University of Colorado, Denver
See details and how to joinNCT05287568 - Phase 1Taking peopleMitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
- Where
- Aurora
- Age
- 18 years to 80 years
- People
- 30
- Run by
- University of Colorado, Denver
See details and how to joinNCT06429449 - Phase 1Taking peopleVenetoclax to Augment Epigenetic Modification and Chemotherapy
- Where
- Milwaukee
- Age
- 1 year to 25 years
- People
- 40
- Run by
- Medical College of Wisconsin
See details and how to joinNCT05317403